Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-440-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute studies are available for all three routes of exposure. No mortality was observed in these studies performed according to the OECD guideline.
Propoxylated neopentylglycol diacrylate is considered to be not harmful or toxic after acute exposure (oral, dermal and inhalation route).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From July 28 to August 14, 1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- 1987
- Deviations:
- yes
- Remarks:
- highest temperature recorded was 26 °C
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan U.K. Ltd, Oxon, England.
- Age at study initiation: Approximately 5-7 weeks
- Weight at study initiation: 122-149 g
- Fasting period before dosing: Overnight
- Fasting period after dosing: 4 h
- Housing: Up to 5 rats/sex in metal cages
- Diet: Standard laboratory rodent diet (Special Diet Services RM1(E) SQC expanded pellet), ad libitum
- Water: Drinking water, ad libitum
- Acclimation period: 15 days
ENVIRONMENTAL CONDITIONS
- Temperature: 21-26 °C
- Humidity: 39-58 %
- Photoperiod: 12 h dark / 12 h artificial light - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- - MAXIMUM DOSE VOLUME APPLIED: 3.147 mL/kg bw in preliminary study and 4.916 mL/kg bw in main study
- DOSAGE PREPARATION: Test substance was administered as supplied (specific gravity 1.017).
- Rationale for the selection of the dosage for main study: Dose was selected based on preliminary study conducted on 1 rat/sex/dose at 3200 mg/kg bw and animals were observed for 7 days. - Doses:
- - Preliminary study: 3200 mg/kg bw
- Main study: 5000 mg/kg bw - No. of animals per sex per dose:
- - Preliminary study: 1
- Main study: 5 - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Mortality: At least twice daily
Clinical signs: Animals were observed soon after dosing and at frequent intervals for the remainder of Day 1; subsequently twice daily for 14 days, with the exception of the day of study termination (Day 15)-morning only.
Bodyweight was recorded on Days 1 (prior to dosing), 8 and 15 for main study.
- Necropsy of survivors performed: Yes, all animals were killed by carbon dioxide asphyxiation at study termination (Day 15). All animals were subjected to a macroscopic examination. - Statistics:
- None
- Preliminary study:
- - No mortality was observed.
- Clinical signs: Piloerection, hunched posture, pallid extremities, increased salivation, abnormal faeces and ungroomed appearance, seen in both rats.
- Bodyweight gain for both rats was considered satisfactory.
- No macroscopic abnormalities were observed in either animal at the terminal necropsy on Day 8. - Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed at 5000 mg/kg bw.
- Clinical signs:
- other: - Piloerection was observed in all rats within 4 minutes of dosing. This sign persisted and was accompanied in rats later on Day 1 and/or at later intervals during the study by increased salivation, abnormal faeces and ungroomed appearance, seen in all ra
- Gross pathology:
- - No macroscopic abnormalities were observed at necropsy.
- Other findings:
- None
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The oral LD50 for SR 9003 is greater than 5000 mg/kg bw in rats as no mortality was observed at this dose level.
- Executive summary:
In an acute oral toxicity study (limit test) performed according to OECD Guideline 401 and in compliance with GLP, groups (5/sex) of CD rats of Sprague Dawley origin [Hsd:Sprague-Dawley (CD)] were given a single oral dose of Propoxylated neopentylglycol diacrylate (SR 9003) at 5000 mg/kg bw. Animals were then observed for mortality, clinical signs and bodyweights for 14 days and were all sacrificed for macroscopic examination. A preliminary study was also conducted on 1 rat/sex/dose at 3200 mg/kg bw and animals were observed for 7 days.
In the preliminary study, no mortality was observed. Piloerection, hunched posture, pallid extremities, increased salivation, abnormal faeces and ungroomed appearance seen in both rats. Bodyweight gain for both rats was considered satisfactory. No macroscopic abnormalities were observed in either animal at the terminal necropsy on Day 8. In the main study, no mortality was observed. Piloerection was observed in all rats within 4 minutes of dosing. This sign persisted and was accompanied in rats later on Day 1 and/or at later intervals during the study by increased salivation, abnormal faeces and ungroomed appearance, seen in all rats. There were no other signs of reaction to treatment and recovery was complete in all instances by Day 4. Bodyweight gain was considered satisfactory in all rats throughout the study. No macroscopic abnormalities were observed for animals killed at study termination on Day 15. In this study, the combined oral LD50 of Propoxylated neopentylglycol diacrylate (SR 9003) was considered to be greater than 5000 mg/kg bw.
The oral LD50 for Propoxylated neopentylglycol diacrylate (SR 9003) is greater than 5000 mg/kg bw in rats therefore it is not classified according to the Annex VI to the Directive 67/548/EEC and the CLP Regulation (EC) N° (1272-2008).
Reference
Table 1: Signs of reaction to treatment
Signs of reaction |
No. of rats in group of 1 * or 5 per sex showing signs |
|||
Dose (mg/kg bw) |
||||
3200* |
5000 |
|||
Male |
Female |
Male |
Female |
|
Piloerection |
1 |
1 |
5 |
5 |
Hunched posture |
1 |
1 |
0 |
0 |
Pallid extremities |
1 |
1 |
0 |
0 |
Increased salivation |
1 |
1 |
5 |
5 |
Abnormal faecesa |
1 |
1 |
5 |
5 |
Ungroomed appearanceb |
1 |
1 |
5 |
5 |
* Preliminary studies comprised one male and one female
a Characterised by soft to liquid faeces
b Characterised by soiled/stained fur around face/muzzle or ano/genital region or wet fur
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- McRae's study is a reliable study performed in accordance with OECD 401 guideline (klimisch score = 1).
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From February 17 to March 10, 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- actual range of humidity was 12-14%; animal selection was not random
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Portage, USA
- Age at study initiation: Approximately 56 days
- Weight at study initiation: 252-268 g (males) and 183-198 g (females)
- Housing: Individually housed in suspended, stainless steel, wire-mesh type cages
- Diet: Certified Rodent Chow® #5002 (PMI Nutrition International, Inc., St Louis, USA), ad libitum
- Water: Water, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature: 65-71 °F
- Humidity: 31-51%
- Photoperiod: 12 h dark / 12 h fluorescent light - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: 52.1 L acrylic and stainless steel nose-only exposure chamber equipped with a stainless steel baffle
- Exposure chamber volume: 52.1 L
- Method of holding animals in test chamber: Animals were removed from their home cages and placed in the nose-only restraint tubes.
- Source and rate of air: Chamber air flow rate of 41 L/minute was supplied by the generation system.
- System of generating particulates/aerosols: Test article was metered from a reservoir through 0.125-inch Teflon® tubing by a liquid pump at a constant rate to an atomizer. The atomizer was operated with in-house compressed air at a pressure of 30 psig, resulting in airflow of 41 L/minute. The test article was atomized to produce a concentrated aerosol in a 4 L glass atomization chamber. Purge air (monitored by a flowmeter) was introduced into the atomization chamber to dilute and sweep the aerosol atmosphere into the exposure chamber.
- Method of particle size determination: Particle size distributions were determined each hour using a cascade impactor to determine the MMAD and GSD.
- Temperature and humidity in air chamber: 22-23 °C and 12-14%, respectively
- Chamber temperature, relative humidity and airflow were continuously monitored throughout the exposures and recorded every 30 minutes.
TEST ATMOSPHERE
- Brief description of analytical method used: Gravimetric method: Chamber atmosphere samples for determination of the test article exposure level were collected at least hourly. The samples were withdrawn from the breathing zone of the test animals in the exposure chamber through glass fiber filters mounted open-faced in a filter holder. The test article concentration was calculated as the filter weight gain in mg divided by the volume of air sampled. The volume of air sampled was calculated as the sample flow rate multiplied by the sample duration.
- Nominal concentration: The amount of test article delivered by the generation system during the exposure was divided by the total volume of air passing through the chamber to give the nominal concentration.
- Samples taken from breathing zone: Yes
- Homogeneity: Samples were obtained prior to initiation of animal exposures to demonstrate that the test article was evenly distributed throughout the breathing zone of the animals.
- Food and water were not available to the animals during the exposure period. Following the required exposure duration, the animals were returned to their individual home cages where food and water were made available.
- Justification for route of administration and exposure levels: The inhalation route is one of the potential routes of human exposure to this test article and the 2 mg/L level was selected as per the regulatory requirement. - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Gravimetric method
- Duration of exposure:
- 4 h
- Concentrations:
- - Nominal concentration: 3.1 mg/L; desired concentration: 2 mg/L ; analytical concentration: 2 ± 0.14 mg/L
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
All animals were observed at least twice daily for morbidity, mortality, injury, and availability of food and water.
Clinical signs were conducted on all animals every 15 minutes during the first exposure hour, hourly for the remaining exposure duration, immediately on removal from the exposure system, at 1, 2 and 4 h post exposure and thereafter once daily for 14 days.
Body weights were recorded immediately prior to exposure (Day 1) and on Days 2, 3, 5, 8 and 15.
- Necropsy of survivors performed: Yes, all animals were killed by overdose of sodium pentobarbital at study termination. The trachea was exposed and clamped such that the lungs could be removed and examined in an inflated state. All major organs in the thoracic and abdominal cavities were observed for gross abnormalities. - Statistics:
- No
- Preliminary study:
- None
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- > 2 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No mortality was observed
- Clinical signs:
- other: - Signs of treatment during the exposure included labored breathing and increased activity. - During the 14 day post exposure period, signs of toxicity included wheezing, labored breathing, excessive lacrimation, rapid respiration, gasping, emaciated, red
- Body weight:
- - There was a minimal effect of the test article exposure on body weight gain.
- All animals temporarily lost weight after the exposure. However, recovery occurred overtime and achieved satisfactory body weight gain in all animals by the end of 14 day observation period. - Gross pathology:
- - No macroscopic abnormalities were observed in any animal.
- Other findings:
- None
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LC50 for Propoxylated neopentylglycol diacrylate (Photomer® 4127) is greater than 2 mg/L (analytical) in rats.
- Executive summary:
In an acute inhalation toxicity study (limit test) performed similarly to the OECD Guideline 403 and in compliance with GLP, groups (5/sex) of Sprague Dawley [Crl:CD® (BR)] rats were exposed to an aerosol atmosphere of a formulation of the Propoxylated neopentylglycol diacrylateP (Photomer® 4127) at concentration of 2 ± 0.14 mg/L air (analytical) for 4 h. Animals were then observed for mortality, clinical signs and bodyweight for 14 days and necropsy was performed in all animals for macroscopic examination.
No mortality was observed. Signs of treatment during the exposure included labored breathing and increased activity. During the 14 day post exposure period, signs of toxicity included wheezing, labored breathing, excessive lacrimation, rapid respiration, gasping, emaciated, red/brown material around the nose and mouth, red eyelids and body surface staining. Males returned to normal within 3 days post exposure and the females returned to normal within 6 days post exposure. There was a minimal effect of the test article exposure on body weight gain. All animals temporarily lost weight after the exposure. However, recovery occurred overtime and achieved satisfactory body weight gain in all animals by the end of 14 day observation period. No macroscopic findings were observed. In this study, the combined inhalational LC50 of Propoxylated neopentylglycol diacrylate (Photomer® 4127) was greater than 2 mg/L air (analytical).
Reference
Table 1: Chamber exposure atmosphere monitoring
Group |
Desired exposure concentration (mg/L) |
Nominal exposure concentration (mg/L) |
Test article exposure concentration (mg/L) |
1 |
2 |
3.1 |
2.0 ± 0.14 |
Table 2: Chamber environment conditions
Group |
Temperature (°C) |
Relative humidity (%) |
Chamber airflow (L/minute) |
Mean ± SD |
Mean ± SD |
Mean ± SD |
|
1 |
23 ± 0.4 |
13 ± 0.6 |
41 ± 0 |
Table 3: Particle size distribution
Group |
Hour |
MMAD (µ) |
GSD |
1 |
1 |
3.51 |
1.40 |
2 |
3.55 |
1.75 |
|
3 |
3.47 |
1.99 |
|
4 |
3.46 |
1.97 |
Table 4: Body weights
Group |
Sex |
|
Pre-exposure |
Day 2 |
Day 3 |
Day 5 |
Day 8 |
Day 15 |
1 |
Male |
Mean |
257.4 |
240.2 |
248.5 |
275.2 |
310.2 |
369.2 |
SD |
6.1 |
10.5 |
13.5 |
10.5 |
12.8 |
17.3 |
||
Female |
Mean |
190.2 |
167.7 |
161.5 |
176.0 |
204.4 |
235.1 |
|
SD |
6.1 |
16.7 |
24.7 |
25.5 |
20.3 |
18.0 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- 0.002 mg/m³ air
- Quality of whole database:
- Hilaski's study is a reliable study which is equivalent to the OECD 403 guideline (klimisch score = 1).
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14 June 2012 - 08 August 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- 1987
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: breeder: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: approximately 8 weeks old on the day of treatment
- Mean body weight at study initiation: the males had a mean body weight of 349 g (range: 346 g to 352 g) and the females had a mean body weight of 245 g (range: 237 g to 257 g)
- Fasting period before study: yes, during the night before treatment
- Housing: polycarbonate cages with stainless steel lids
- Diet: SSNIFF R/M-H pelleted diet (free access)
- Water: tap water filtered with a 0.22 µm filter (free access)
- Acclimation period: the animals were acclimated to the study conditions for a period of 5 (females) or 8 (males) days before treatment.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2°C
- Humidity (%): 50 ± 20%
- Air changes (per hr): approximately 12 cycles/hour of filtered, non-recycled air
- Photoperiod (hrs dark / hrs light): 12 h/12 h.
IN-LIFE DATES: 26 June 2012 to 13 July 2012. - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 10% of body surface, dorsal site
- Type of wrap if used: hydrophilic gauze pad + adhesive hypoallergenic aerated semi-occlusive dressing + restraining bandage
REMOVAL OF TEST SUBSTANCE
- Removal of dressing: 24h post-exposure
- Washing: at 24h post-exposure, with a moistened cotton pad
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 20 mL/kg
- Constant volume: no. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg.
- No. of animals per sex per dose:
- 5 animals per group.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Clinical observations: frequently during the hours following treatment; then, at least once a day.
- Body weight: just before treatment on day 1; then on days 8 and 15.
- Necropsy of survivors performed: yes (macroscopic). - Statistics:
- no
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No unscheduled deaths occurred during the study.
- Clinical signs:
- other: No clinical signs indicative of systemic toxicity were observed in any animals. Very slight or well-defined erythema was noted at application sites of all females and 4/5 males between days 2 and 8, except in one female for which moderate to severe erythe
- Gross pathology:
- No macroscopic test item-related findings were observed.
The macroscopic findings correlated with common histological findings in control rats, and thus were considered to be incidental. - Other findings:
- no
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The dermal LD50 of the test item was higher than 2000 mg/kg in rats as no mortality occured as this dose level.
- Executive summary:
The objective of this study was to evaluate the potential toxicity of the test item following a single dermal application to rats.
This study was performed according to the international guidelines (OECD No. 402 and Council Regulation No. 440/2008 of 30 May 2008, Part B.3) and in compliance with the principles of Good Laboratory Practice.
Methods
The test item was applied in its original form to the skin of five female then five male Sprague-Dawley rats at the dose-level of 2000 mg/kg. The application site was covered by a semi-occlusive dressing for 24 hours.
Each animal was observed at least once a day for mortality and clinical signs for 15 days. From day 2, any local reactions at the treatment site were also noted. Body weight was recorded on day 1 and then on days 8 and 15.
On completion of the observation period, the animals were sacrificed and then submitted for a macroscopic post-mortem examination. Macroscopic lesions were preserved in buffered formalin then destroyed at the finalization of the study report as no microscopic examination was performed.
Results
No unscheduled deaths and no clinical signs indicative of systemic toxicity were observed in any animals.
Very slight or well-defined erythema was noted at application sites of females and males between days 2 andsingle female had a more severe erythema on days 2 and 3 a long with moderate edema and, until day 7, scabs. Various minor degrees of edema (days 2 to 5), dryness (days 3 to 9), and scabs (days 4 to 11) were also observed in a few other females and males.
When compared to CiToxLAB France historical control data, a lower body weight gain was noted in all males and females between day 1 and day 8. Their body weight gain returned to normal thereafter. The body weight of males was not affected by the test item treatment.
No macroscopic test item-related findings were observed.
Conclusion
The dermal LD50 of the test item was higher than 2000 mg/kg in rats.
Therefore, the test item is not classified as toxic or harmful by dermal route according to the criteria of CLP Regulation.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Silvano's study is a reliable study performed in accordance with OECD 402 guideline (klimisch score = 1).
Additional information
Acute toxicity : via oral route
In an acute oral toxicity study (McRae 1998) performed according to OECD Guideline 401 and in compliance with GLP, groups (5/sex) of CD rats of Sprague Dawley origin [Hsd:Sprague-Dawley (CD)] were given a single oral dose of Propoxylated neopentylglycol diacrylate at 5000 mg/kg bw. Animals were then observed for mortality, clinical signs and bodyweights for 14 days and were all sacrificed for macroscopic examination. A preliminary study was also conducted on 1 rat/sex/dose at 3200 mg/kg bw and animals were observed for 7 days.
In the preliminary study, no mortality was observed. Piloerection, hunched posture, pallid extremities, increased salivation, abnormal faeces and ungroomed appearance seen in both rats. Bodyweight gain for both rats was considered satisfactory. No macroscopic abnormalities were observed in either animal at the terminal necropsy on Day 8. In the main study, no mortality was observed. Piloerection was observed in all rats within 4 minutes of dosing. This sign persisted and was accompanied in rats later on Day 1 and/or at later intervals during the study by increased salivation, abnormal faeces and ungroomed appearance, seen in all rats. There were no other signs of reaction to treatment and recovery was complete in all instances by Day 4. Bodyweight gain was considered satisfactory in all rats throughout the study. No macroscopic abnormalities were observed for animals killed at study termination on Day 15. In this study, the combined oral LD50 of Propoxylated neopentylglycol diacrylate was considered to be greater than 5000 mg/kg bw.
Acute toxicity : via inhalation route
In an acute inhalation toxicity study (Hilaski 1999) performed similarly to the OECD Guideline 403 and in compliance with GLP, groups (5/sex) of Sprague Dawley [Crl:CD® (BR)] rats were exposed to an aerosol atmosphere of a formulation of the Propoxylated neopentylglycol diacrylate at concentration of 2 ± 0.14 mg/L air (analytical) for 4 h. Animals were then observed for mortality, clinical signs and bodyweight for 14 days and necropsy was performed in all animals for macroscopic examination.
No mortality was observed. Signs of treatment during the exposure included labored breathing and increased activity. During the 14 day post exposure period, signs of toxicity included wheezing, labored breathing, excessive lacrimation, rapid respiration, gasping, emaciated, red/brown material around the nose and mouth, red eyelids and body surface staining. Males returned to normal within 3 days post exposure and the females returned to normal within 6 days post exposure. There was a minimal effect of the test article exposure on body weight gain. All animals temporarily lost weight after the exposure. However, recovery occurred overtime and achieved satisfactory body weight gain in all animals by the end of 14 day observation period. No macroscopic findings were observed. In this study, the combined inhalational LC50 of Propoxylated neopentylglycol diacrylate was greater than 2 mg/L air (analytical).
Acute toxicity : via dermal route on rats (OECD 402)
The test item was applied in its original form to the skin of five female then five male Sprague-Dawley rats at the dose-level of 2000 mg/kg. The application site was covered by a semi-occlusive dressing for 24 hours. No unscheduled deaths and no clinical signs indicative of systemic toxicity were observed in any animals during the 14 -day observation period. Very slight or well-defined erythema was noted at application sites of females and males between days 2 and single female had a more severe erythema on days 2 and 3 a long with moderate edema and, until day 7, scabs. Various minor degrees of edema (days 2 to 5), dryness (days 3 to 9), and scabs (days 4 to 11) were also observed in a few other females and males. When compared to historical control data, a lower body weight gain was noted in all males and females between day 1 and day 8. Their body weight gain returned to normal thereafter. The body weight of males was not affected by the test item treatment. No macroscopic test item-related findings were observed.
The dermal LD50 of Propoxylated neopentylglycol diacrylate was higher than 2000 mg/kg bw in rats.
Justification for classification or non-classification
Based on the available data, no classification for acute toxicity is required for Propoxylated neopentylglycol diacrylate according to the Regulation (EC) No 1272/2008.
Justification for oral route : LD0> 5000 mg/kg bw.
Justification for inhalation : There is no mortality at 2 mg/L (maximal attainable concentration), and clinical signs were reversible in 7 days
Justification for dermal route: LD0> 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.